Injectable click-crosslinked hydrogel containing resveratrol to improve the therapeutic effect in triple negative breast cancer
Open Access
- 5 August 2022
- journal article
- research article
- Published by Elsevier in Materials Today Bio
- Vol. 16, 100386
Abstract
No abstract availableKeywords
Funding Information
- National Research Foundation of Korea (2019M3D1A1078938, 2019R1A6A1A11051471)
This publication has 45 references indexed in Scilit:
- Co-delivery of resveratrol and docetaxel via polymeric micelles to improve the treatment of drug-resistant tumorsAsian Journal of Pharmaceutical Sciences, 2019
- Hyaluronidases: A Therapeutic EnzymeProtein & Peptide Letters, 2018
- Metastatic and triple-negative breast cancer: challenges and treatment optionsDrug Delivery and Translational Research, 2018
- Triple negative breast cancer: new therapeutic approaches and BRCA statusAPMIS, 2018
- Physical and Pharmacokinetic Characterizations of trans-Resveratrol (t-Rev) Encapsulated with Self-Assembling Lecithin-based Mixed Polymeric Micelles (saLMPMs)Scientific Reports, 2017
- Triple-negative breast cancer: challenges and opportunities of a heterogeneous diseaseNature Reviews Clinical Oncology, 2016
- Curcumin and Resveratrol as Promising Natural Remedies with Nanomedicine Approach for the Effective Treatment of Triple Negative Breast CancerJournal of Oncology, 2016
- Stimuli-Responsive InjectableIn situ-Forming Hydrogels for Regenerative MedicinesPolymer Reviews, 2015
- Injectable and biodegradable hydrogels: gelation, biodegradation and biomedical applicationsChemical Society Reviews, 2011
- Metabolites and tissue distribution of resveratrol in the pigMolecular Nutrition & Food Research, 2011